Intracranial atherosclerosis (ICAS) is a progressive pathological process that causes
progressive stenosis and cerebral hypoperfusion and is a major cause of stroke occurrence …

Drug-eluting stent (DES) is a potential endovascular treatment for patients with symptomatic
intracranial atherosclerotic disease (sICAD). However, evidence regarding the treatment of …

Background and Purpose—Although recent trials have suggested that stenting is worse than
medical therapy for patients with severe symptomatic intracranial atherosclerotic stenosis, it …

BACKGROUND AND PURPOSE: Acute basilar occlusions have a poor prognosis without
recanalization. Many have underlying severe atherosclerotic intracranial stenosis coexisting …

Background and purpose A multicentre prospective registry study of individually tailored
stenting for a patient with symptomatic intracranial atherosclerotic stenosis (ICAS) combined …

Purpose To investigate the imaging and clinical outcomes of emergent angioplasty and/or
stenting or neither in patients of emergent large-vessel occlusion (ELVO) with underlying …

Background Intracranial angioplasty with a self-expandable stent (SES) is an important
endovascular therapy for symptomatic intracranial arterial stenosis. We sought to update the …

Objective To evaluate the clinical outcomes of early stenting (≤ 14 days) or late stenting (>
14 days) in patients who underwent intracranial stent placement. Methods Patients with …

Background: Percutaneous transluminal angioplasty and stenting with the Wingspan stent
has proven safe and effective in patients with middle cerebral artery stenosis (MCAS), but …

Background Intracranial vertebrobasilar artery stenosis is an important cause of ischemic
stroke. With its high resolution, intravascular optical coherence tomography (OCT) provides …